Growth Metrics

Pfizer (PFE) Exchange Rate Effect (2016 - 2026)

Pfizer has reported Exchange Rate Effect over the past 18 years, most recently at $19.0 million for Q1 2026.

  • Quarterly Exchange Rate Effect rose 371.43% to $19.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $67.0 million through Mar 2026, up 174.44% year-over-year, with the annual reading at $41.0 million for FY2025, 162.12% up from the prior year.
  • Exchange Rate Effect was $19.0 million for Q1 2026 at Pfizer, up from $5.0 million in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $41.0 million in Q2 2025 and troughed at -$139.0 million in Q4 2022.
  • The 5-year median for Exchange Rate Effect is -$5.0 million (2023), against an average of -$17.9 million.
  • Year-over-year, Exchange Rate Effect crashed 1420.0% in 2022 and then skyrocketed 371.43% in 2026.
  • A 5-year view of Exchange Rate Effect shows it stood at -$139.0 million in 2022, then surged by 99.28% to -$1.0 million in 2023, then crashed by 3600.0% to -$37.0 million in 2024, then soared by 113.51% to $5.0 million in 2025, then skyrocketed by 280.0% to $19.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Exchange Rate Effect are $19.0 million (Q1 2026), $5.0 million (Q4 2025), and $2.0 million (Q3 2025).